Researchers from the Organoid group (formerly the Clevers group) have improved human small intestinal organoids—miniature versions of the small intestine. This will help them to better study the functioning of the small ...
Aug 23, 2022
0
22
A new study led by Marc Veldhoen, group leader at the Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) and Associate Professor at Faculdade de Medicina de Lisboa (FMUL) and published today in the scientific ...
Aug 15, 2022
0
860
Although Aduhelm, a monoclonal antibody targeting amyloid beta (Aβ), recently became the first US FDA approved drug for Alzheimer's disease (AD) based on its ability to decrease Aβ plaque burden in AD patients, its effect ...
Aug 4, 2022
0
42
A unique subset of white blood cells confers fast-acting and lasting protection against ischemic stroke in mice, University of Pittsburgh neurologists and immunologists reported in the Journal of Clinical Investigation today.
Aug 1, 2022
0
117
The bacterium Staphylococcus aureus has long been known to cause infections in humans, ranging from mild skin infections to pneumonia to more serious infections of the heart. In high-income countries, it's the leading cause ...
Jul 21, 2022
0
52
Researchers at Duke University have captured days-long time-lapse videos of young neural cells moving and growing within a novel 3D synthetic biocompatible structure. By literally watching how the cells respond to natural ...
Jul 18, 2022
0
69
A new insight into RNA regulation has taken researchers a big step forward in understanding how the body creates platelets.
Jul 5, 2022
0
37
The human liver has amazing regeneration capabilities: Even if up to 70 percent of it is removed, the remaining tissue can regrow a full-sized liver within months.
Jun 27, 2022
0
120
Breast cancer is one of the most common forms of cancer, according to the World Health Organization (WHO). Each year, around 2.3 million people worldwide contract the disease. If doctors detect breast cancer early enough, ...
Jun 22, 2022
0
632
Investigators from Cedars-Sinai Cancer have discovered that cancerous tumors called soft-tissue sarcomas produce a protein that switches immune cells from tumor-attacking to tumor-promoting. The study, published today in ...
Jun 21, 2022
0
285
